Regeneration of Pancreatic &bgr;-Cells in vivo as a Potential Therapeutic Approach for Diabetes Mellitus

E-ISSN： 2212-3334|3|2|135-143

ISSN： 1872-2148

Source： Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol.3, Iss.2, 2009-06, pp. : 135-143

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Two Faces of Protein Palmitoylation in Islet &bgr;-Cell Function: Potential Implications in the Pathophysiology of Islet Metabolic Dysregulation and Diabetes

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 7, Iss. 3, 2013-01 ,pp. : 203-212

Bentham Science Publishers

Access to resources Recommend Favorite

GLP-1 as a Therapeutic Agent in Patients with Type 2 Diabetes Mellitus

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 1, Iss. 3, 2007-11 ,pp. : 193-201

Bentham Science Publishers

Access to resources Recommend Favorite

Isoform Selective Phosphoinositide 3-Kinase amp;#947; and amp;#948; Inhibitors and Their Therapeutic Potential

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 2, Iss. 1, 2008-01 ,pp. : 1-10

Bentham Science Publishers

Access to resources Recommend Favorite

Relevance of Dyslipidaemia and its Consequences in Periodontal Patients with Co-Existing Cardiovascular Disease and Diabetes Mellitus: Therapeutic Targets

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 3, Iss. 3, 2009-11 ,pp. : 214-224

Bentham Science Publishers

Access to resources Recommend Favorite

Challenges for the Treatment of Diabetes Mellitus

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 5, Iss. 3, 2011-09 ,pp. : 203-209

Bentham Science Publishers

Access to resources Recommend Favorite